Beneficial effects of combination therapy with pioglitazone and dapagliflozin on diabetic nephropathy in db/db mice

被引：0
作者：
Han, E. [1 ]
Cho, Y. [2 ]
Lee, Y-H [2 ]
Lee, B-W [2 ]
Kang, E. [2 ]
Cha, B-S [2 ]
机构：
[1] Keimyung Univ, Sch Med, Daegu, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1192
引用
收藏
页码：S549 / S549
页数：1
相关论文
共 50 条
  • [31] NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice
    Yang, Shu
    Liu, Mengyang
    Chen, Yuanli
    Ma, Chuanrui
    Liu, Lipei
    Zhao, Buchang
    Wang, Yong
    Li, Xiaoju
    Zhu, Yan
    Gao, Xiumei
    Kong, Deling
    Duan, Yajun
    Han, Jihong
    Yang, Xiaoxiao
    SCIENTIFIC REPORTS, 2018, 8
  • [32] PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
    Park, CW
    Zhang, Y
    Zhang, X
    Wu, J
    Chen, L
    Cha, DR
    Su, D
    Hwang, MT
    Fan, X
    Davis, L
    Striker, G
    Zheng, F
    Breyer, M
    Guan, Y
    KIDNEY INTERNATIONAL, 2006, 69 (09) : 1511 - 1517
  • [33] D-carnosine prevents diabetic nephropathy in db/db mice
    Iacobini, C.
    Menini, S.
    Ricci, C.
    Scipioni, A.
    Blasetti-Fantauzzi, C.
    Giaccari, A.
    Salomone, E.
    Lapolla, A.
    Orioli, M.
    Aldini, G.
    Pugliese, F.
    Pugliese, G.
    DIABETOLOGIA, 2010, 53 : S51 - S51
  • [34] The olive constituent oleuropein exerts nephritic protective effects on diabetic nephropathy in db/db mice
    Liu, Yan
    Dai, Wu
    Ye, Shandong
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2022, 128 (02) : 455 - 462
  • [35] Efficacy of aliskiren, compared with angiotensin II blockade, in slowing the progression of diabetic nephropathy in db/db mice: should the combination therapy be a focus?
    Zhou, Guangyu
    Liu, Xia
    Cheung, Alfred K.
    Huang, Yufeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (05): : 825 - 840
  • [36] Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone
    Makino, Hisashi
    Miyamoto, Yoshihiro
    Sawai, Kazutomo
    Mori, Kiyoshi
    Mukoyama, Masashi
    Nakao, Kazuwa
    Yoshimasa, Yasunao
    Suga, Shin-ichi
    DIABETES, 2006, 55 (10) : 2747 - 2756
  • [37] Effect of pioglitazone on metabolic features in endotoxemia model in obese diabetic db/db mice
    Sharma, Manoranjan
    Mohapatra, Jogeswar
    Malik, Umar
    Nagar, Jignesh
    Chatterjee, Abhijit
    Ramachandran, Balaraman
    Jain, Mukul R.
    JOURNAL OF DIABETES, 2017, 9 (06) : 613 - 621
  • [38] Hepatocyte growth factor gene therapy slows down the progression of diabetic nephropathy in db/db mice
    Kagawa, Tomoyo
    Takemura, Genzou
    Kosai, Ken-ichiro
    Murata, Ichijiro
    Ohno, Takamasa
    Takahashi, Tomoyuki
    Esaki, Masayasu
    Maruyama, Rumi
    Fujiwara, Takako
    Ohashi, Hiroshige
    Fujiwara, Hisayoshi
    NEPHRON PHYSIOLOGY, 2006, 102 (3-4): : 92 - 102
  • [39] Renoprotective Effects of Canagliflozin in Db/db Diabetic Mice
    Thanekar, Unmesha
    Gill, Rupinder K.
    Dhakal, Sanjeev
    Hosawi, Anhar
    Elased, Khalid M.
    HYPERTENSION, 2019, 74
  • [40] The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice
    Ninichuk, Volha
    Khandoga, Alexander G.
    Segerer, Stephan
    Loetscher, Pius
    Schlapbach, Achim
    Revesz, Laszlo
    Feifel, Roland
    Khandoga, Andrej
    Krombach, Fritz
    Nelson, Peter J.
    Schloendorff, Detlef
    Anders, Hans-Joachim
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (04) : 1267 - 1276
12345